Page last updated: 2024-11-04

sb 202190 and Allergic Contact Dermatitis

sb 202190 has been researched along with Allergic Contact Dermatitis in 2 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Research Excerpts

ExcerptRelevanceReference
" This study investigates for the first time the role of MK2 in skin inflammation using the model of oxazolone-induced acute allergic contact dermatitis in mice."3.75Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice. ( Bibby, BM; Funding, AT; Gaestel, M; Iversen, L; Johansen, C; Kragballe, K; Lilleholt, LL, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Funding, AT1
Johansen, C1
Gaestel, M1
Bibby, BM1
Lilleholt, LL1
Kragballe, K1
Iversen, L1
Matos, TJ1
Duarte, CB1
Gonçalo, M1
Lopes, MC1

Other Studies

2 other studies available for sb 202190 and Allergic Contact Dermatitis

ArticleYear
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.
    The Journal of investigative dermatology, 2009, Volume: 129, Issue:4

    Topics: Animals; Dermatitis, Allergic Contact; Imidazoles; Interferon-gamma; Interleukin-1beta; Intracellula

2009
DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells.
    Journal of dermatological science, 2005, Volume: 39, Issue:2

    Topics: Active Transport, Cell Nucleus; Animals; Blotting, Western; CD40 Antigens; Cell Line; Cells, Culture

2005